PharmaZell, the manufacturer of active pharmaceutical ingredients (APIs) and partner of the pharmaceutical industry, recently opened its new production facility in Vizag, India (Visakhapatnam, Andra Pradesh) for the manufacture of the API Mesalamine (5-ASA).
[more...]
01.07.2008: White biochemicals - PharmaZell patents new biocatalyst
Keeping pace with the technological breakthroughs in the fields of biotransformation, fermentation and metabolic engineering, PharmaZell – in close collaboration with Stuttgart University's Institute of Technical Biochemistry (ITB) – has developed a new biocatalyst for the selective synthesis of a highly advanced pharmaceutical compound, expressing it in a recombinant E. coli strain.
[more...]
15.04.2008: PharmaZell opens new development center in India - Development work on active generic substances and exclusive customer developments
Having set up a development group in Chennai, pharmaceuticals manufacturer PharmaZell has now opened a second development center in India at Vizag (Visakhapatnam): PharmaZell R&D (India) Private Limited.
[more...]
